US 7354919
Isoxazole compositions useful as inhibitors of ERK
granted A61PA61P1/00A61P1/02
Quick answer
US patent 7354919 (Isoxazole compositions useful as inhibitors of ERK) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/16, A61P1/18